Livermore, California – In its most recent annual report, Sandia National Labs featured an article on Sensor-Kinesis’ breakthrough advancements in adapting the Sandia’s shear horizontal surface acoustic wave (SH-SAW) biosensor array technology into a portable handheld device that will be capable of providing rapid quantitative detection of disease carrying pathogens as well as disease indicative biomarkers at a far earlier stage and at a lower cost point than current methodologies allow.

In creating an inexpensive biodetection platform to link disease biology to digital analysis in a way where reliable data can be assessed easily and inexpensively, and then be shared via secure digital networks instantly to an appropriate treating physician or agency, is expected to created a major beneficial shift in providing early detection preventative care for patients facing a wide variety of disease issues. Potential applications include tumor- and organ-based cancer detection, coronary and central-nervous system disease, as well as foodborne, waterborne and airborne pathogens.

The partnership between Sandia and Sensor-Kinesis Corp. is poised to make the vision of real-time early disease detection available at a patient, local physician, or ground zero field level a reality.

About Sandia National Laboratories

The Sandia National Laboratories(Sandia) are two major United States Department of Energy research and development laboratories. They are operated and managed by National Technology and Engineering Solutions of Sandia, LLC., a wholly owned subsidiary of Honeywell International, Inc. Sandia, LLC operates Sandia as a contractor for the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) and supports numerous federal, state, and local government agencies, companies, and organizations.

Operating out of Albuquerque, New Mexico and Livermore, California, Sandia is built on a strong science, technology, and engineering foundation to enable Sandia to be at the forefront of innovation, collaborative research with universities and companies, and discretionary research projects with significant potential impact. They are the nation’s premier science and engineering laboratory for national security and technology innovation,

For additional info visit:

About SKC

SKC is an early-stage high technology medical device company that aims to optimize healing of the human body through proprietary local Smart Drug Delivery Systems™ (SDDS) and associated advanced devices to measure biological responses.

This news release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements are based upon the current beliefs and expectations of the management of Sensor-Kinesis Corporation and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

For additional information on any of the press releases shown here, please contact:
Sensor-Kinesis Corporation
Phone: 310.641.2700